Duodenal ulcer, Gastric ulcer, Nonsteroidal Anti-Inflammatory Drug (NSAID) associated gastric and duodenal ulcers or erosions Helicobacter pylori eradication in peptic ulcer disease. Reflux oesophangitis. Symptomatic gastro-oesophageal reflux disease. Treatment of erosive reflux oesophangitis, Long-term maintenance therapy to prevent reflux oesophagitis, Acid-related dyspepsia, Zollinger-Ellison syndrome, Refractory peptic ulcer, Prophylaxis of acid aspiration.

This is not a substitute for consulting your doctor. Seek professional advice if you are experiencing any illness or symptoms.

Doudenal ulcer_ Usually 20 mg once daily for 2 weeks; if not fully healed, treatment may be extended for a further 2 weeks. In refractory case, 40 mg once daily for 4 weeks. Gastric ulcer and relux oesophagitis_ 20 mg once daily for 4 weeks; if not fully healed, treatment may be extended for further 4 weeks. In refractory cases, 40 mg once daily for 8 weeks. Prevention of relapses in patients with severe reflux oesophagitis- 20 mg once daily. In case of recurrence, the dose can be increased to 40 mg once daily. Helicobacter pylori-associated peptic ulcer disease-40-80 mg with amoxicillin. 1.5 to 3g daily in divided doses for 2 weeks or 40 mg daily with clarithromycin 500 mg thrice daily for 2 weeks. Zollinger-Ellison Syndrome- 60 mg once daily adjusted to response. Usual maintenance -20 to 120mg daily. Doses over 80mg daily, can be given in two divided doses. Prophylaxis of acid aspiration-Omeprazole 40mg in the evening before surgery and 40mg 2-6 hours before surgery.